FindMyKOL
Clinical trialNCT05834621WithdrawnObservational

AMNIOmics: A Prenatal Rapid Genome Validation Study

NCT05834621 is an observational study sponsored by Mayo Clinic. As of 21 Nov 2026, it was withdrawn. It studies Amniocentesis Affecting Fetus or Newborn, Family Members and 2 more conditions. The registry lists an enrollment of 0 participants. The registry lists a start date of 7 Jan 2025 and a primary completion date of 7 Jan 2025.

SponsorMayo Clinic →Enrollment0Amniocentesis Affecting Fetus or NewbornFamily MembersGenetic Predisposition SuspectedMultiple Anomalies of Fetus
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT05834621
FieldValue
Registry IDNCT05834621
StatusWithdrawn
Study typeObservational study
Lead sponsorMayo Clinic
Enrollment0
ConditionsAmniocentesis Affecting Fetus or Newborn, Family Members, Genetic Predisposition Suspected and Multiple Anomalies of Fetus
Start7 Jan 2025
Primary completion7 Jan 2025
Study completion7 Jan 2025
Last update posted5 Sept 2025

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to validate Whole Genome Sequencing (WGS) on amniotic fluid to reduce the time to diagnosis and enhance the care for the fetus/neonate.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT05834621

Each answer restates registry values shown on this page.

What is NCT05834621?

NCT05834621 is an observational study sponsored by Mayo Clinic. It studies Amniocentesis Affecting Fetus or Newborn, Family Members and 2 more conditions.

Who leads NCT05834621?

The registry names Myra Wick, MD, PhD (principal investigator, Mayo Clinic) as the overall official.

When did NCT05834621 end?

The registry lists a primary completion date of 7 Jan 2025 and a study completion date of 7 Jan 2025. The sponsor last updated the record on 5 Sept 2025.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.